Abstract
Introduction
Several avenues of evidence have shown that extracellular adenosine induces apoptosis in a variety of cancer cells via diverse signaling pathways linked to adenosine transporters and adenosine receptors. For adenosine transporter-mediated pathway, intracellularly transported adenosine induces apoptosis in GT3-TKB human lung cancer cells and HuH-7 human hepatoma cells under the control of AMP-activated protein kinase (AMPK), that is activated by adenosine kinase-catalyzed conversion to AMP [1, 2] . Intracellularly transported adenosine, alternatively, downregulates expression of c-FLIP to neutralize caspase-8 inhibition due to c-FLIP, resulting in the activation of caspase-8 and the effector caspase-3, responsible for HuH-7 cell apoptosis [3] . Intracellularly transported adenosine still activates caspase-3 by neutralizing caspase-3 inhibition due to inhibitor of apoptosis protein (IAP) as a result of decreased IAP2 expression and reduced IAP activity in response to increased DIABLO expression and DIABLO release from damaged mitochondria in HuH-7 cells, regardless of caspase-9 activation [4] .
Adenosine receptors include A 1 , A 2a , A 2b , and A 3 receptors. For adenosine receptormediated pathway, G i protein-coupled A 1 adenosine receptor mediates apoptosis in CW2 human colonic cancer cells by activating caspase-3, -8, and -9 [5] . Adenosine also induces apoptosis in both the pathways linked to A 1 adenosine receptor and AMPK-dependent caspase-3/-9 activation following adenosine uptake into cells [6] . G s protein-coupled A 2a adenosine receptor mediates apoptosis in Caco-2 human colonic cancer cells by activating caspase-9/-3 [7] . A 3 adenosine receptor, that is linked to G i or G q protein, mediates apoptosis in human lung cancer cells, breast cancer cells, hepatocellular carcinoma cells, and thyroid cancer cells [8] [9] [10] [11] .
Apoptosis is induced in a caspase-dependent and -independent manner. Apoptosisinducing factor (AIF), that is localized in the mitochondria under the normal conditions, is engaged in caspase-independent apoptosis. Apoptotic signals trigger to release AIF from the mitochondria and deliver into the nucleus, where AIF binds to the nuclear DNA, causing chromosomal condensation, margination, and large-scale DNA fragmentation, to induce apoptosis. As is the case with AIF, AIF-homologous mitochondrion-associated inducer of death (AMID), a human pro-apoptotic protein, also induces caspase-independent apoptosis by accumulating in the nucleus from the mitochondria or the cytoplasm [12] . We have earlier found that adenosine induces HuH-7 cell apoptosis by upregulating AMID expression [13] . Then, we wondered whether adenosine could induce apoptosis in other cancer cells by the similar mechanism.
To address this question, we explored adenosine-induced apoptosis in SBC-3 human lung cancer cells and the underlying pathway. We show here that adenosine induces SBC-3 cell apoptosis by upregulating AMID expression as mediated via A 3 adenosine receptor and increasing AMID localization in the nucleus.
Materials and Methods
Cell culture SBC-3 cells, purchased from Health Science Research Resources Bank (Osaka, Japan), were grown in MEM supplemented with 10% (v/v) heat-inactivated FBS, 0.1 mM non-essential amino acids, penicillin (�inal concentration, 100 U/ml), and streptomycin (�inal concentration, 0.1 mg/ml), in a humidi�ied atmosphere of 5% CO 2 and 95% air at 37 °C.
Assay of cell viability
Cell viability was assayed by the method using 3-(4,5-dimethyl-2-thiazolyl)-2,5-diphenyl-2H-tetrazolium bromide (MTT) as described previously [1] . To assess cell viability, percentage against basal untreated MTT intensities was calculated.
Real-time reverse transcription-polymerase chain reaction (RT-PCR)
Real-time RT-PCR was carried out using primers shown in Table 1 by the method as described previously [14] . Signal intensities for the AMID mRNA was normalized by those for the GAPDH mRNA.
Separation into the nuclear and cytosolic components
Lysed cells were centrifuged at 3,500 rpm for 5 min at 4 °C. The pellet and supernatant were used as nuclei-and cytosol-enriched components.
Western blotting
Western blotting was carried out using an anti-A 1 receptor antibody (Oncogene, Cambridge, MA, USA), an anti-A 2a receptor antibody (Oncogene), an anti-A 2b receptor antibody (Santa Cruz Biotechnology, Santa Cruz, CA, USA), an anti-A 3 receptor antibody (Santa Cruz Biotechnology), an anti-AMID antibody (GeneTex, Inc., Irvine, CA, USA), or an anti-β-actin antibody (Sigma, St Louis, MO, USA) by the method as described previously [14] . Intensities for each protein were normalized by β-actin intensities.
Statistical analysis
Statistical analysis was carried out using unpaired t-test and Dunnett's test.
Results

Adenosine induces SBC-3 cell apoptosis as mediated via A 3 adenosine receptor
We initially examined the effect of extracellular adenosine on SBC-3 cell death. Adenosine reduced SBC-3 cell viability in a concentration (0.01-10 mM)-and treatment time (24-72 h)-dependent manner (Fig. 1A) . This interprets that adenosine reduces SBC-3 cell viability due to cell death or cell growth arrest. In the TUNEL staining analysis, TUNEL-positive cells occupied approximately 70% of total cells after adenosine treatment, while TUNEL-positive -(3-iodobenzyl)-adenosine-5'-N-methyl-uronamide (2-Cl-IB-MECA) for 24-48 h reduced SBC-3 cell viability in a concentration (1-100 µM)-dependent manner (Fig. 1C) . Collectively, adenosine is likely to induce SBC-3 cell death as mediated via A 3 adenosine receptor.
To obtain further evidence for the implication of A 3 adenosine receptor in adenosineinduced SBC-3 cell death, the A 3 R siRNA was constructed. SBC-3 cells express all the adenosine receptor proteins, and expression of the A 3 adenosine receptor protein was evidently suppressed in cells transfected with the A 3 R siRNA (Fig. 3A) , con�irming A 3 adenosine receptor knock-down. Adenosine-induced SBC-3 cell death was signi�icantly prevented for cells transfected with the A 3 R siRNA as compared with that for cells transfected with the NC siRNA (Fig. 3B) . Moreover, TUNEL-positive cells after adenosine treatment were signi�icantly decreased by knocking-down A 3 adenosine receptor (Fig. 3C) . Overall, these results provide evidence for A 3 adenosine receptor-dependent SBC-3 cell apoptosis.
A 3 adenosine receptor is linked to G i protein involving adenylate cyclase inhibition and G q protein involving phospholipase C activation [15] . Adenosine-induced SBC-3 cell death was not affected by forskolin, an activator of adenylate cyclase, GF109203X, an inhibitor of protein kinase C (PKC), PD98059, an inhibitor of mitogen-activated protein (MAP) kinase kinase (MEK), or the Src family inhibitors PP2 and/or SrcI1 (Fig. 1D ). This suggests that of AMID in the nuclear component in parallel with decreased presence in the cytosolic component (Fig. 5) . This indicates that adenosine promotes AMID translocation into the nucleus.
Expression of the AMID protein was clearly suppressed in SBC-3 cells transfected with the AMID siRNA (Fig. 6A) , con�irming AMID knock-down. In the MTT assay, adenosineinduced SBC-3 cell death was signi�icantly prevented by knocking-down AMID (Fig. 6B) . In the TUNEL staining analysis, TUNEL-positive cells after adenosine treatment were signi�icantly decreased by silencing the AMID-targeted gene (Fig. 6C) . Overall, these results draw a conclusion that adenosine upregulates AMID expression as mediated via A 3 adenosine receptor and promotes AMID translocation into the nucleus, to induce SBC-3 cell apoptosis.
Discussion
The results of the present study demonstrate that extracellular adenosine induces apoptosis in SBC-3 human lung cancer cells in a concentration (0.01-10 mM)-and treatment time (24-72 h)-dependent manner. The adenosine effect was not affected by the adenosine transporter inhibitor dipyridamole, ruling out participation of the intrinsic pathway relevant to adenosine uptake into cells and the ensuing signaling. In contrast, adenosine-induced SBC-3 cell death was suppressed by the A 3 adenosine receptor inhibitor MRS1191, but not inhibitors for A 1 , A 2a , and A 2b adenosine receptors, or knocking-down A 3 adenosine receptor. In addition, the A 3 adenosine receptor agonist 2-Cl-IB-MECA induced SBC-3 cell apoptosis in a fashion that mimics the adenosine effect. These results indicate that adenosine induces SBC-3 cell apoptosis via A 3 adenosine receptor. receptors such as A 1 , A 2a , A 2b , and A 3 receptors [3] . One of the underlying mechanisms is explained by upregulation of AMID expression and nuclear AMID accumulation [13] . Intracellularly transported adenosine, alternatively, induces apoptosis in MCF-7 human breast cancer cells by accumulating AMID in the nucleus in an adenosine receptor-independent manner [16] .
In the present study, adenosine increased expression of the AMID mRNA and protein in SBC-3 cells. Amazingly, adenosine-induced upregulation of AMID expression was suppressed by knocking-down A 3 adenosine receptor. This accounts for the implication of A 3 adenosine receptor in the regulation of the AMID gene transcription. Moreover, adenosine increased nuclear AMID in parallel with decreased cytosolic AMID in SBC-3 cells, indicating that adenosine promotes AMID translocation from the cytosol into the nucleus. Expectedly, adenosine-induced SBC-3 cell death was also prevented by knocking-down AMID. Taken together, these results lead to a conclusion that adenosine induces SBC-3 cell apoptosis by upregulating AMID expression and accumulating AMID in the nucleus via A 3 adenosine receptor. In further support of the note, extracellular adenosine induced apoptosis in RCC4-VHL human renal cancer cells by the similar mechanism, i.e., by upregulating AMID expression and promoting AMID translocation from the cytosol into the nucleus in an A 3 adenosine receptor-dependent manner (unpublished data). AMID, thus, may be a key executioner for adenosine-induced apoptosis both via an intrinsic pathway relevant to adenosine uptake and an extrinsic pathway relevant to adenosine receptors including A 3 adenosine receptor.
In our earlier studies, adenosine induced apoptosis in other human lung cancer cell lines such as A549 cells, an epithelial adenocarcinoma cell line, and Lu-65 cells, a giant cell cancer cell line, via A 3 adenosine receptor [14, 17] . Surprisingly, A 3 adenosine receptor-mediated apoptotic signaling pathways differed between these two cell lines; A549 cell apoptosis was induced by upregulating expression of Bax, Bad, and Puma, to disrupt mitochondrial membrane potentials and to activate caspase-9 followed by the effector caspase-3 [14] and Lu-65 cell apoptosis was induced by upregulating p53 expression, to promote p53-dependent Noxa gene transcription, causing activation of caspase-9 in association with disruption of
